[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Views 232
Citations 0
Correction
November 2019

Missing eTable

JAMA Oncol. 2019;5(11):1643. doi:10.1001/jamaoncol.2019.5486

In the Original Investigation titled “Response Rate Following Albumin-Bound Paclitaxel Plus Gemcitabine Plus Cisplatin Treatment Among Patients With Advanced Pancreatic Cancer: A Phase 1b/2 Pilot Clinical Trial,”1 published in JAMA Oncology online first on October 3, 2019, eTable 3 was missing from Supplement 2. It has been added to Supplement 2 and cited in the Results. This article was corrected online.

References
1.
Jameson  GS, Borazanci  E, Babiker  HM.  Response rate following albumin-bound paclitaxel plus gemcitabine plus cisplatin treatment among patients with advanced pancreatic cancer: a phase 1b/2 pilot clinical trial  [published online October 3, 2019].  JAMA Oncol. doi:10.1001/jamaoncol.2019.3394Google Scholar
×